Revision aid, not clinical advice. This page is educational material written for exam preparation. It is not a substitute for the current guideline or for clinical judgement, and must not be relied on for the care of any individual. Always check up-to-date national guidance and verify independently before acting on anything here.

AKT Statistics Guide · Part 3 · Chapter 9

The Prevalence Trap: PPV & NPV

Your patient’s test came back positive — how worried should you be? That answer depends on prevalence, and it is the single most important diagnostic idea for GP practice.

▶Watch the tutorial · 7 min — the same 90% test, two different settings, and why a positive can be a coin flip.

Where this shows up in the AKT

  • Interpreting what a result actually means for the individual patient in front of you.
  • Screening low-risk populations — and the false-positive problem that follows.
  • The classic trap of treating sensitivity and PPV as the same thing. They are not (Chapter 8).

Sensitivity and specificity start from a question you can only ask in a study: if I already know who has the disease, how does the test behave? Predictive values flip it round and start from the result. They follow directly from sensitivity and specificity — but, crucially, they also depend on how common the disease is.

Start from the result, not the disease

Where sensitivity and specificity begin with known disease status, predictive values begin with the test result:

Positive predictive value (PPV)

  • PPV = TP / (TP + FP) — of everyone who tests positive, the proportion who genuinely have the disease.

Negative predictive value (NPV)

  • NPV = TN / (TN + FN) — of everyone who tests negative, the proportion who are genuinely clear.

Sensitivity and specificity are fixed properties of the test. PPV and NPV are not — they move with prevalence. That single fact is what trips candidates up, so let us see it happen.

Worked example — same test, two settings

A coeliac-disease test is 90% sensitive and 95% specific. The test never changes. Only the population does.

Hospital clinic — prevalence 10%

1,000 patients, 100 with the disease, 900 without:

Prevalence 10%. Sensitivity 90%, specificity 95%.
Disease + (100)Disease − (900)Total
Test +9045135
Test −10855865
  • PPV = 90 / 135 = 67% — two-thirds of the positives are real.
  • NPV = 855 / 865 = 99% — a negative here is very reassuring.

GP population — prevalence 1%

Same 1,000 patients, but now only 10 have the disease and 990 do not:

Prevalence 1%. Identical test: sensitivity 90%, specificity 95%.
Disease + (10)Disease − (990)Total
Test +949.558.5
Test −1940.5941.5
  • PPV = 9 / 58.5 ≈ 15% — now only about one positive in seven is real.

Same test. In hospital, two-thirds of positives are true; in GP, roughly one in seven. Most of your positive results are now false positives. The test did not get worse — the maths of low prevalence did this. (The decimal cells are an artefact of scaling to 1,000; the proportions are what matter.)

PPV against disease prevalence for a fixed test

The same test (90% sensitive, 95% specific) gives a very different PPV with prevalence: about 67% in a 10% hospital clinic, but only ~15% at 1% in primary care.

Why this matters clinically

  • Do not trust a positive test on its own when prevalence is low — the pre-test probability matters (Chapter 10).
  • This is why a hospital-grade test can perform poorly when imported into GP without thought: same test, far lower prevalence.
  • PPV rises with prevalence, so we target screening at higher-risk groups; NPV rises as prevalence falls.
  • Screen a low-risk population for a rare disease and you drown in false positives — which is exactly why every screening programme needs a confirmatory test before anyone is told they are ill.
The one line to remember: sensitivity and specificity are fixed properties of the test; PPV and NPV move with prevalence. Low prevalence means low PPV — confirm before you alarm.

The traps that cost marks

Trap 1 — assuming a positive means disease. It depends entirely on prevalence. A “good test” in a low-prevalence setting still throws up mostly false positives.
Trap 2 — forgetting which numbers move. PPV and NPV change dramatically with prevalence; sensitivity and specificity (and the likelihood ratios) do not.
Trap 3 — alarming the patient too early. Frightening someone over a positive screening result before the confirmatory test is back is the clinical version of this error.
AKT-style question

A new test for coeliac disease has a sensitivity of 90% and a specificity of 95%. In a GP population where the prevalence of coeliac disease is 1%, a patient tests positive. Which statement is most accurate?

  • The patient almost certainly has coeliac disease
  • The test has ruled the disease in
  • Most positive results will still be false positives
  • The test is not sensitive enough for primary care
Reveal answer

C — most positive results will still be false positives. Even with excellent sensitivity and specificity, a low-prevalence setting like GP massively reduces the PPV. At 1% prevalence the PPV here is only about 15%, so most positives are false alarms — the classic Prevalence Trap. The test characteristics are fine; it is the population, not the test, that makes a lone positive untrustworthy.

Lock it in

  • PPV = TP / (TP + FP): of the positives, who truly has it. NPV = TN / (TN + FN): of the negatives, who is truly clear.
  • Both depend on prevalence — sensitivity and specificity do not.
  • Low prevalence drives PPV down: even a great test yields mostly false positives in a low-risk group.
  • So target testing at higher-risk groups, and confirm before you alarm.
Source concepts: standard diagnostic-test methodology (e.g. Centre for Evidence-Based Medicine; NICE diagnostics guidance). A revision summary, not a clinical protocol.

Want more questions like this one?

Try the free 20-question AKT taster: sixteen clinical, two evidence-based practice and two admin questions, with the reasoning after each and a marked report. No card needed. The full AKT Pack has 2,000+ more.

Note: Independent revision resource for the MRCGP AKT and the MSRA. Educational content for exam preparation only — not clinical advice, and not affiliated with the RCGP. A study aid, not a substitute for the official curriculum or clinical judgement.

← Back to the AKT Statistics Guide

by Core Revision · corerevision.com